PostEra Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 43

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $68M

  • Investors
  • 16

PostEra General Information

Description

Developer of an AI-driven drug discovery platform designed to accelerate the traditionally manual process of medicinal chemistry. The company offers a machine learning-based system that iteratively refines candidate drugs, designs synthetic routes, and guides experimental testing, enabling biopharma partners to accelerate pipeline development while advancing its own internal drug discovery efforts.

Contact Information

Website
www.postera.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • One Broadway
  • 14th Floor
  • Cambridge, MA 02142
  • United States
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Discovery Tools (Healthcare)
Vertical(s)
Big Data, Artificial Intelligence & Machine Learning, Life Sciences, Mobile
Corporate Office
  • One Broadway
  • 14th Floor
  • Cambridge, MA 02142
  • United States

PostEra Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PostEra Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 30-May-2022 $68M Completed Generating Revenue
6. Early Stage VC (Series A) 14-Jan-2022 Completed Generating Revenue
5. Grant 27-Sep-2021 Completed Generating Revenue
4. Seed Round 06-Apr-2020 Completed Generating Revenue
3. Accelerator/Incubator 18-Mar-2020 Completed Generating Revenue
2. Accelerator/Incubator 01-Sep-2019 Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view PostEra’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

PostEra Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an AI-driven drug discovery platform designed to accelerate the traditionally manual process of medicinal c
Biotechnology
Cambridge, MA
43 As of 2025

Burlingame, CA
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PostEra Competitors (3)

One of PostEra’s 3 competitors is Genesis Therapeutics, a Venture Capital-Backed company based in Burlingame, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genesis Therapeutics Venture Capital-Backed Burlingame, CA
InSilico Medicine Venture Capital-Backed Boston, MA
Atomwise Venture Capital-Backed San Francisco, CA
You’re viewing 3 of 3 competitors. Get the full list »

PostEra Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PostEra Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institute for Allergy and Infectious Disease Government
Breyer Capital Venture Capital Minority
I2BF Global Ventures Venture Capital Minority
Lifeforce Capital Venture Capital Minority
The Clermont Group Impact Investing Minority
You’re viewing 5 of 16 investors. Get the full list »

Ready to get started?

Request a free trial

PostEra FAQs

  • When was PostEra founded?

    PostEra was founded in 2019.

  • Where is PostEra headquartered?

    PostEra is headquartered in Cambridge, MA.

  • What is the size of PostEra?

    PostEra has 43 total employees.

  • What industry is PostEra in?

    PostEra’s primary industry is Biotechnology.

  • Is PostEra a private or public company?

    PostEra is a Private company.

  • What is PostEra’s current revenue?

    The current revenue for PostEra is .

  • How much funding has PostEra raised over time?

    PostEra has raised $28.6M.

  • Who are PostEra’s investors?

    National Institute for Allergy and Infectious Disease, Breyer Capital, I2BF Global Ventures, Lifeforce Capital, and The Clermont Group are 5 of 16 investors who have invested in PostEra.

  • Who are PostEra’s competitors?

    Genesis Therapeutics, InSilico Medicine, and Atomwise are competitors of PostEra.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »